Cellular Mechanisms of Opioid Tolerance
阿片类药物耐受的细胞机制
基本信息
- 批准号:7466744
- 负责人:
- 金额:$ 1.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-05-01 至 2008-04-30
- 项目状态:已结题
- 来源:
- 关键词:Adenylate CyclaseAnalgesicsAttenuatedBackBehavioralBindingChronicDevelopmentEventFeedbackGoalsIn VitroKnowledgeLateralLeadLinkMeasuresMicroinjectionsMolecularMorphineNeuronsNumbersOpioidOpioid ReceptorOutputPainPathway interactionsPharmaceutical PreparationsPlayPotassium ChannelResearchResearch PersonnelResistanceRoleSeriesSignal PathwaySignal TransductionSpinal CordSystemTechniquesTestingWhole-Cell Recordingsbasebehavior measurementclinically relevantextracellularimprovedin vivomidbrain central gray substancemu opioid receptorsneurochemistryneuromechanismneuronal circuitryneurotransmissionpreventprogramsreceptorreceptor bindingreceptor internalizationrelating to nervous systemresearch studytherapy developmentvoltage
项目摘要
Opioids are the most effective treatment for pain. Unfortunately, their efficacy decreases with repeated administration
because of the development of tolerance. The broad long-term objective of this research is to understand the
underlying neural mechanisms for tolerance so more effective pain treatments can be developed. Many previous
studies have examined opioid tolerance. However, these studies show over 30 different mechanisms for tolerance, and
it is unlikely that all of these putative mechanisms are directly involved. The proposed studies will focus on tolerance in
the ventrolateral periaqueductal gray (PAG) in an attempt to identify causal mechanisms for tolerance. PAG neurons
are particularly well suited for studying opioid tolerance because microinjection of morphine into the PAG produces
antinociception and repeated microinjections produce tolerance. In addition, the neuronal circuitry and intracellular
signaling cascades through which opioids produce antinociception have been described. The proposed studies will take
advantage of both intracellular and behavioral measures of tolerance in an attempt to understand the neurochemical
basis of tolerance in these neurons. Tolerance could be caused by a change anywhere along the signaling pathway
from opioid receptors to feedback circuits. The aims of this project will examine all of the steps along this pathway. Aim
1 will identify the specific PAG neurons that contribute to opioid tolerance. Aim 2 will determine whether receptor
internalization contributes to the development of tolerance. Aim 3 will identify the intracellular molecules that contribute
to the development of tolerance. And Aim 4 will determine whether feedback to the PAG is necessary for the
development of tolerance. A unique feature of this project is that whole cell recordings will be used to link neuronal
changes to behavioral measures of tolerance. For example, the intracellular signaling cascades believed to contribute
to tolerance will be systematically disrupted to determine the contribution of each step in this signaling cascade to
opioid tolerance measured behaviorally. The combined use of in vivo and in vitro techniques provides a powerful
approach to understanding the link between molecular changes and behavioral consequences. In the long term, such
knowledge will contribute to the development of therapies that improve pain treatment by preventing tolerance to
opioids.
阿片类药物是治疗疼痛最有效的药物。不幸的是,它们的功效随着重复给药而降低
因为宽容的发展。这项研究的长期目标是了解
潜在的神经耐受机制,因此可以开发更有效的疼痛治疗方法。许多先前
研究已经检查了阿片类药物耐受性。然而,这些研究显示了超过30种不同的耐受机制,
不可能所有这些假定的机制都直接参与。拟议的研究将侧重于
腹外侧导水管周围灰质(PAG),试图确定耐受的因果机制。PAG神经元
特别适合于研究阿片类药物耐受性,因为将吗啡微量注射到PAG中会产生
抗伤害感受和重复显微注射产生耐受性。此外,神经元回路和细胞内
已经描述了阿片样物质通过其产生抗伤害感受的信号级联。拟议的研究将采取
细胞内和行为的耐受性措施的优势,试图了解神经化学
这些神经元的耐受性基础。耐受性可能是由信号通路沿着任何地方的变化引起的
从阿片受体到反馈回路本项目的目标将检查沿着这条道路的所有步骤沿着。目的
1将确定有助于阿片耐受的特定PAG神经元。目的2将决定受体是否
内化有助于宽容的发展。目标3将确定细胞内分子,
发展宽容。目标4将确定是否需要向PAG提供反馈,
宽容的发展。该项目的一个独特之处是,整个细胞记录将用于连接神经元
改变行为耐受性的测量方法。例如,细胞内信号级联被认为有助于
将系统地破坏耐受性,以确定该信号级联中的每个步骤对
阿片类药物耐受性的测量行为。体内和体外技术的组合使用提供了强有力的
了解分子变化和行为后果之间联系的方法。从长远来看,这样的
知识将有助于开发通过防止对疼痛的耐受来改善疼痛治疗的疗法。
阿片类药物
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL M MORGAN其他文献
MICHAEL M MORGAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL M MORGAN', 18)}}的其他基金
MOR/DOR Heterodimer Antagonists: A Novel Treatment for Opioid Dependence
MOR/DOR 异二聚体拮抗剂:阿片类药物依赖的新型治疗方法
- 批准号:
9918310 - 财政年份:2019
- 资助金额:
$ 1.76万 - 项目类别:
Neural Mechanisms for Enhanced Cannabinoid/Opioid Antinociception
增强大麻素/阿片类镇痛作用的神经机制
- 批准号:
7640433 - 财政年份:2009
- 资助金额:
$ 1.76万 - 项目类别:
Neural Mechanisms for Enhanced Cannabinoid/Opioid Antinociception
增强大麻素/阿片类镇痛作用的神经机制
- 批准号:
7843446 - 财政年份:2009
- 资助金额:
$ 1.76万 - 项目类别:
相似海外基金
Planning Study for the Development of Sigma 2 ligands as Analgesics
Sigma 2 配体镇痛药开发规划研究
- 批准号:
10641500 - 财政年份:2023
- 资助金额:
$ 1.76万 - 项目类别:
Designing and validating optimal nonaddictive analgesics using the CANDO paradigm
使用 CANDO 范式设计和验证最佳的非成瘾性镇痛药
- 批准号:
10485593 - 财政年份:2023
- 资助金额:
$ 1.76万 - 项目类别:
Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain
植物 hHv1 通道阻滞剂作为神经性疼痛镇痛药的鉴定
- 批准号:
10728526 - 财政年份:2023
- 资助金额:
$ 1.76万 - 项目类别:
Designed Multiple Ligands as Non-opioid Analgesics for Treating Chronic Pain
设计多种配体作为非阿片类镇痛药,用于治疗慢性疼痛
- 批准号:
10621646 - 财政年份:2023
- 资助金额:
$ 1.76万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10425794 - 财政年份:2022
- 资助金额:
$ 1.76万 - 项目类别:
Elucidation of the mechanism of pain suppression by exercise and development of new analgesics
阐明运动镇痛机制及开发新型镇痛药
- 批准号:
22K19602 - 财政年份:2022
- 资助金额:
$ 1.76万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
大麻素 CB1 受体变构靶向开发非成瘾性小分子镇痛药
- 批准号:
10512672 - 财政年份:2022
- 资助金额:
$ 1.76万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10721752 - 财政年份:2022
- 资助金额:
$ 1.76万 - 项目类别:
A novel clinically-relevant mouse model of chronic overlapping pain conditions for screening analgesics
用于筛选镇痛药的新型临床相关慢性重叠疼痛小鼠模型
- 批准号:
10821681 - 财政年份:2022
- 资助金额:
$ 1.76万 - 项目类别:














{{item.name}}会员




